Atlas Trials

Usher Syndrome Type 2

6 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Usher Syndrome Type 2

RecordFirmDate
Study to Evaluate the Efficacy Safety and Tolerability of QR-421a in Subjects With RP Due to Mutations in Exon 13 of the USH2A Gene With Early to Moderate Vision Loss (Celeste) (NCT05176717)Laboratoires Thea2021-12-15
Study to Evaluate the Efficacy Safety and Tolerability of Ultevursen in Subjects With RP Due to Mutations in Exon 13 of the USH2A Gene (Sirius) (NCT05158296)Laboratoires Thea2021-12-08
An Open-Label Extension Study to Evaluate Safety & Tolerability of QR-421a in Subjects With Retinitis Pigmentosa (NCT05085964)Laboratoires Thea2021-09-16
Study to Evaluate Safety and Tolerability of QR-421a in Subjects With RP Due to Mutations in Exon 13 of the USH2A Gene (NCT03780257)ProQR Therapeutics2019-03-06
Retinal Imaging in CNTF -Releasing Encapsulated Cell Implant Treated Patients for Early-stage Retinitis Pigmentosa (NCT01530659)Neurotech Pharmaceuticals2012-01-01

Track Usher Syndrome Type 2 automatically

Every clearance here is in the API, with alerts when new ones post.